View Information Collection (IC) List View Supporting Statement and Other Documents
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.


View ICR - OIRA Conclusion



0910-0497 200603-0910-001
Historical Active 200509-0910-008
HHS/FDA
Focus Groups as Used by the Food and Drug Administration
Extension without change of a currently approved collection   No
Regular
Approved without change 05/04/2006
Retrieve Notice of Action (NOA) 03/03/2006
This generic clearance for FDA focus groups is approved for 18 months under the following conditions: 1) FDA shall submit memos for individual focus groups (e.g., statement of need, intended use of information, description of respondents, information collection procedures, justification for incentive, estimated burden, participant screener, and moderator guide). 2) OMB will respond with clearance or questions within 10 working days 3) OMB and FDA will jointly evaluate the generic clearance upon resubmission in 18 months. Upon resubmission, FDA will provide a summary of each collection approved under the generic clearance (e.g., use of information).
  Inventory as of this Action Requested Previously Approved
11/30/2007 11/30/2007 05/31/2006
2,574 0 1,674
4,252 0 2,830
0 0 0